Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001615774-15-000409
Filing Date
2015-03-05
Accepted
2015-03-05 14:44:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D s100838_sc13d.htm SC 13D 27143
  Complete submission text file 0001615774-15-000409.txt   28723
Mailing Address DANDRIT BIOTECH A/S FRUEBJERGVEJ 3 BOX 62 2100 COPENHAGEN G7
Business Address DANDRIT BIOTECH A/S FRUEBJERGVEJ 3 BOX 62 2100 COPENHAGEN G7 45 39179840
DanDrit Biotech USA, Inc. (Subject) CIK: 0001527728 (see all company filings)

EIN.: 452259340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-86428 | Film No.: 15677017
SIC: 2834 Pharmaceutical Preparations

Mailing Address GENERATORVEJ 8D HERLEV G7 2730
Business Address GENERATORVEJ 8D HERLEV G7 2730 305-539-3300
Karsten Ree Holding B ApS (Filed by) CIK: 0001635706 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: SC 13D